New Retina Radio:

The Art of Drug Choice

The Art of Drug Choice logo.

03.24.22

Art of Drug Choice: Treating New Wet AMD Patients

Have innovations in therapy actually led to a paradigm shift when it comes to encountering patients with newly diagnosed wet AMD? In the season finale of “The Art of Drug Choice,” moderator Arshad M. Khanani, MD, MA, is joined by panelists Lejla Vajzovic, MD, and Joseph M. Coney, MD, to review strategies for treating new wet AMD patients, to discuss where new technologies fit into a treatment algorithm, and to examine the best time to switch patients to a new therapeutic option. After the break, Dr. Khanani updates the panel on a patient case shared in previous seasons of this series, which involves a patient with a 12-year treatment history who experienced significant vision loss following a change in therapy. How did Dr. Khanani manage the case—and what happened after inflammation was brought under control?   This editorially independent podcast is supported with advertising.

Other Podcast Episodes

03.24.22

Art of Drug Choice: Treating New Wet AMD Patients

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD

03.17.22

Art of Drug Choice: Who Is Best Suited for Extended-duration Therapy?

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD; and Joseph M. Coney, MD

03.03.22

Art of Drug Choice: The Latest Advances in Wet AMD Therapy

Arshad M. Khanani, MD, MA; Lejla Vajzovic, MD, and Joseph M. Coney, MD

09.10.21

The Art of Drug Choice: International Panel in Wet AMD: Safety Data

Arshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC

09.01.21

The Art of Drug Choice: International Panel in Wet AMD: The Pipeline

Arshad M. Khanani, MD; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; Peter Kertes, MD, FRCSC

08.20.21

The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch

Arshad Khanani, MD, MA; Justus Garweg, MD; Seenu Hariprasad, MD; Peter Kertes, MD, FRCSC

08.06.21

The Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes Sense

Arshad M. Khanani, MD, MA; Justus G. Garweg, MD; Seenu M. Hariprasad, MD; and Peter Kertes, MD, FRCSC

11.19.20

The Art of Drug Choice: Safety in Wet AMD

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

11.19.20

The Art of Drug Choice: Wet AMD Pipeline

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA

11.19.20

The Art of Drug Choice: Phase 3 Trials in Wet AMD

Arshad M. Khanani, MD, MA; Christopher G. Fuller, MD; Nikolas J.S. London, MD, FACS; and Christina Y. Weng, MD, MBA